Diffusion-weighted images offer diagnostic potential in abdomen
Parallel imaging has opened the door to diffusion-weighted imaging of the body. A diffusion-weighted transverse image of a rectal lesion (m-shaped dark area in top image) in an 83-year-old man corresponds to the pathological specimen (bottom image). Abnormal signal near the bladder (black dot upper middle of top image) is an artifact from the intestines.
Parallel imaging has opened the door to diffusion-weighted imaging of the body. A diffusion-weighted transverse image of a rectal lesion (m-shaped dark area in top image) in an 83-year-old man corresponds to the pathological specimen (bottom image). Abnormal signal near the bladder (black dot upper middle of top image) is an artifact from the intestines.
The diffusion-weighted image was obtained using Toshiba's version of parallel imaging, called SPEEDER, which achieves an in-plane isotropic resolution of 0.5 mm on an Excelart 1.5T Vantage system. The high-resolution map of the malignancy was generated by radiologists at Hasuda Hospital in Hasuda, Japan, using an eight-channel torso coil and a SPEEDER factor of 1.6. Data acquisition was performed in four minutes.
Japanese radiologists expect this application, when used in combination with T1- and T2-weighted imaging, to improve tumor detectability and contribute to the differential diagnosis of benign and malignant lesions. They have successfully applied diffusion-weighted imaging to the diagnosis of pancreatic cancer, lymphoma, and lung cancer. (Provided by Dr. Shizuaki Maejima, Hasuda Hospital)
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
